Literature DB >> 22542608

Coenzyme Q10 deficiency in patients with Parkinson's disease.

Laurie K Mischley1, Jason Allen, Ryan Bradley.   

Abstract

UNLABELLED: Reactive oxygen species (ROS) are well known to contribute to the pathophysiology of Parkinson's disease (PD). Clinical trials of antioxidants are currently underway in PD patients, however, antioxidant research has been hindered by a lack of peripheral biomarkers.
METHODS: Twenty-two patients with PD elected to have a novel antioxidant assessment (Functional Intracellular Assay (FIA), SpectraCell Lab, Houston, TX) performed between 2004 and 2008. Each PD case was compared to four age- and gender-matched controls (n=88) in four separate, random iterations using laboratory data submitted during the same time period. Logistic regression was used to determine the odds of functional deficiency in antioxidant nutrients (i.e., glutathione, coenzyme Q10, selenium, vitamin E and alpha-lipoic acid) by case-control status. The proportion of cases with functional deficiency was also compared to that for controls by chi(2) test.
RESULTS: Compared to cases, PD patients had a significantly greater odds of deficiency in coenzyme Q10 status (OR: 4.7-5.4; 95% CI: 1.5-17.7; P=0.003-0.009) based on FIA results, but not of vitamin E, selenium, lipoic acid, or glutathione (all P>0.05). The proportion of cases with coenzyme Q10 deficiency was also significantly greater in cases than in controls (32-36% vs. 8-9%; P=0.0012-0.006).
CONCLUSIONS: Deficiency of coenzyme Q10 assessed via FIA should be explored as a potential peripheral biomarker of antioxidant status in PD.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22542608      PMCID: PMC3366011          DOI: 10.1016/j.jns.2012.03.023

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  25 in total

Review 1.  Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.

Authors:  M Ebadi; P Govitrapong; S Sharma; D Muralikrishnan; S Shavali; L Pellett; R Schafer; C Albano; J Eken
Journal:  Biol Signals Recept       Date:  2001 May-Aug

2.  Coenzyme Q10 serum levels in Huntington's disease.

Authors:  J Andrich; C Saft; M Gerlach; B Schneider; A Arz; W Kuhn; Th Müller
Journal:  J Neural Transm Suppl       Date:  2004

3.  Development of a chemically defined serum- and protein-free medium for growth of human peripheral lymphocytes.

Authors:  W Shive; F Pinkerton; J Humphreys; M M Johnson; W G Hamilton; K S Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

Review 4.  Nutritional requirements for growth of human lymphocytes.

Authors:  W Shive; K S Matthews
Journal:  Annu Rev Nutr       Date:  1988       Impact factor: 11.848

5.  Altered redox state of platelet coenzyme Q10 in Parkinson's disease.

Authors:  M E Götz; A Gerstner; R Harth; A Dirr; B Janetzky; W Kuhn; P Riederer; M Gerlach
Journal:  J Neural Transm (Vienna)       Date:  2000       Impact factor: 3.575

6.  Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.

Authors:  Clifford W Shults; David Oakes; Karl Kieburtz; M Flint Beal; Richard Haas; Sandy Plumb; Jorge L Juncos; John Nutt; Ira Shoulson; Julie Carter; Katie Kompoliti; Joel S Perlmutter; Stephen Reich; Matthew Stern; Ray L Watts; Roger Kurlan; Eric Molho; Madaline Harrison; Mark Lew
Journal:  Arch Neurol       Date:  2002-10

7.  Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease.

Authors:  Makoto Sohmiya; Makoto Tanaka; Nyou Wei Tak; Makoto Yanagisawa; Yutaka Tanino; Yoko Suzuki; Koichi Okamoto; Yorihiro Yamamoto
Journal:  J Neurol Sci       Date:  2004-08-30       Impact factor: 3.181

8.  Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease.

Authors:  Clifford W Shults; M Flint Beal; David Song; Deborah Fontaine
Journal:  Exp Neurol       Date:  2004-08       Impact factor: 5.330

9.  Effect of coenzyme Q10 on the mitochondrial function of skin fibroblasts from Parkinson patients.

Authors:  Kirstin Winkler-Stuck; Falk R Wiedemann; Claus-W Wallesch; Wolfram S Kunz
Journal:  J Neurol Sci       Date:  2004-05-15       Impact factor: 3.181

10.  Oxidative stress in skin fibroblasts cultures from patients with Parkinson's disease.

Authors:  Pilar del Hoyo; Alberto García-Redondo; Fernando de Bustos; José Antonio Molina; Youssef Sayed; Hortensia Alonso-Navarro; Luis Caballero; Joaquín Arenas; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  BMC Neurol       Date:  2010-10-19       Impact factor: 2.474

View more
  20 in total

Review 1.  Biomarkers for Parkinson's Disease: Recent Advancement.

Authors:  Sharvari Lotankar; Kedar S Prabhavalkar; Lokesh K Bhatt
Journal:  Neurosci Bull       Date:  2017-09-21       Impact factor: 5.203

Review 2.  Coenzyme Q10 and Parkinsonian Syndromes: A Systematic Review.

Authors:  Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  J Pers Med       Date:  2022-06-15

Review 3.  Coenzyme Q10 effects in neurological diseases.

Authors:  H Rauchová
Journal:  Physiol Res       Date:  2021-12-30       Impact factor: 2.139

Review 4.  Mitochondrial enhancement for neurodegenerative movement disorders: a systematic review of trials involving creatine, coenzyme Q10, idebenone and mitoquinone.

Authors:  Jia Liu; Lu-ning Wang
Journal:  CNS Drugs       Date:  2014-01       Impact factor: 5.749

5.  Association of the COQ2 V393A Variant with Parkinson's Disease: A Case-Control Study and Meta-Analysis.

Authors:  Xinglong Yang; Jing Xi; Quanzhen Zhao; Hua Jia; Ran An; Zhuolin Liu; Yanming Xu
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

6.  Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers.

Authors:  Jonathan Polussa; Andrea Schneider; Randi Hagerman
Journal:  Brain Disord Ther       Date:  2014

Review 7.  Current experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials.

Authors:  Giovanni Pagano; Annarita Aiello Talamanca; Giuseppe Castello; Mario D Cordero; Marco d'Ischia; Maria Nicola Gadaleta; Federico V Pallardó; Sandra Petrović; Luca Tiano; Adriana Zatterale
Journal:  Int J Mol Sci       Date:  2014-11-05       Impact factor: 5.923

8.  Coenzyme Q10 Levels Are Decreased in the Cerebellum of Multiple-System Atrophy Patients.

Authors:  Lucia V Schottlaender; Conceição Bettencourt; Aoife P Kiely; Annapurna Chalasani; Viruna Neergheen; Janice L Holton; Iain Hargreaves; Henry Houlden
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

9.  Minimal mitochondrial respiration is required to prevent cell death by inhibition of mTOR signaling in CoQ-deficient cells.

Authors:  Ying Wang; Siegfried Hekimi
Journal:  Cell Death Discov       Date:  2021-08-04

Review 10.  Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies.

Authors:  Giovanni Pagano; Annarita Aiello Talamanca; Giuseppe Castello; Mario D Cordero; Marco d'Ischia; Maria Nicola Gadaleta; Federico V Pallardó; Sandra Petrović; Luca Tiano; Adriana Zatterale
Journal:  Oxid Med Cell Longev       Date:  2014-05-04       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.